Is Opzelura a High Risk Medication? Understanding the Boxed Warning and Safety Profile
•
4 min read
The US Food and Drug Administration has issued a boxed warning for Opzelura (ruxolitinib) cream, signaling potential serious side effects. This places Opzelura in a category of medications requiring careful consideration of its risks versus benefits. Understanding the context of the boxed warning is crucial for answering the question: is Opzelura a high risk medication?.